Diagnosing and treating contrast-induced acute kidney injury in 2017
- PMID: 28740653
- PMCID: PMC5506171
- DOI: 10.21037/jtd.2017.05.58
Diagnosing and treating contrast-induced acute kidney injury in 2017
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment in
-
Intravenous hydration according to current guidelines in the prevention of contrast induced nephropathy-the AMACING trial.J Thorac Dis. 2017 Jul;9(7):E656-E657. doi: 10.21037/jtd.2017.06.80. J Thorac Dis. 2017. PMID: 28840037 Free PMC article. No abstract available.
Comment on
-
Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.Lancet. 2017 Apr 1;389(10076):1312-1322. doi: 10.1016/S0140-6736(17)30057-0. Epub 2017 Feb 21. Lancet. 2017. PMID: 28233565 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources